Can the status of the Breast and Ovarian Cancer Susceptibility Gene 1 product (BRCA1) predict response to taxane-based cancer therapy?

por DeLigio, J. Thomas, Velkova, Aneliya, Zorio, Diego A.R., Monteiro, Alvaro N.A.
Publicado 2009